CIK 0001649094 · Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464233385
- Phone
- 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,185,988
- in 8 filings, $4.8M under 10b5-1 plans
Net −$5,185,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-03 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −1,195 | $116.42 | $139K | 207,513 |
| 2024-09-03 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −10 | $117.03 | $1K | 207,503 |
| 2024-09-03 | Wassil Jim CHIEF OPERATING OFFICER | Shares withheld for taxes 10b5-1 | −5,545 | $110.15 | $611K | 201,958 |
| 2024-09-03 | Wassil Jim CHIEF OPERATING OFFICER | Option exercise · Stock Option (right to buy) 10b5-1 | −10,000 | 52,638 | ||
| 2024-09-03 | GUGGENHIME ANDREW PRESIDENT AND CFO | Shares withheld for taxes | −6,337 | $110.15 | $698K | 90,383 |
| 2024-09-03 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Shares withheld for taxes | −13,669 | $110.15 | $1.5M | 465,219 |
| 2024-09-03 | Cowan Elvia SVP, FINANCE | Option exercise 10b5-1 | +5,000 | $25.92 | $130K | 17,723 |
| 2024-09-03 | Cowan Elvia SVP, FINANCE | Sale 10b5-1 | −5,000 | $107.67 | $538K | 12,723 |
| 2024-09-03 | Cowan Elvia SVP, FINANCE | Shares withheld for taxes 10b5-1 | −1,145 | $110.15 | $126K | 11,578 |
| 2024-09-03 | Cowan Elvia SVP, FINANCE | Option exercise · Stock Option (right to buy) 10b5-1 | −5,000 | 114,000 | ||
| 2024-09-03 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Option exercise 10b5-1 | +1,667 | $21.41 | $36K | 32,493 |
| 2024-09-03 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −4 | $107.67 | $431 | 32,489 |
| 2024-09-03 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −523 | $110.45 | $58K | 31,966 |
| 2024-09-03 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −715 | $111.57 | $80K | 31,251 |
| 2024-09-03 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −122 | $112.66 | $14K | 31,129 |
| 2024-09-03 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −79 | $114.96 | $9K | 31,050 |
| 2024-09-03 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −144 | $116.01 | $17K | 30,906 |
| 2024-09-03 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −80 | $117.28 | $9K | 30,826 |
| 2024-09-03 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Shares withheld for taxes 10b5-1 | −2,203 | $110.15 | $243K | 28,623 |
| 2024-09-03 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Option exercise · Stock Option (right to buy) 10b5-1 | −1,667 | 179,997 |
Page 23 of 39 · 764 trades